THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION AS STIPULATED UNDER THE UK VERSION OF THE MARKET ABUSE REGULATION NO 596/2014 WHICH IS PART OF ENGLISH LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018, AS AMENDED. ON PUBLICATION OF THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INFORMATION IS CONSIDERED TO BE IN THE PUBLIC DOMAIN.
1 April 2022
CYBA plc
Director / PDMR Share Dealing
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
CYBA plc ("CYBA" or the "Company") confirms the sale of shares by the following Directors and Persons Discharging Managerial Responsibility ("PDMR"):
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||
a) | Name | Ben Schmidt | ||||
2 | Reason for the notification | |||||
a) | Position/status | Director - Narf Industries | ||||
b) | Initial notification/ Amendment | Initial notification | ||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||
a) | Name | Cyba Plc | ||||
b) | LEI | 213800K484JECP4RK284 | ||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||
a) | Description of the financial instrument, type of instrument
Identification code | Ordinary shares of £0.0001p each in Cyba Plc
GB00BMH18M705 | ||||
b) | Nature of the transaction | Sale of Ordinary shares | ||||
c) | Price(s) and volume(s) |
| ||||
d) | Aggregated information
| N/A
| ||||
e) | Date of the transaction | 1 April 2022 | ||||
f) | Place of the transaction | London Stock Exchange |
ENDS
About CYBA plc
CYBA plc ("CYBA") is a Group operating in the Cyber Security sector. Its strategy is focussed on building a group capable of offering Cyber and Cybersecurity solutions in the US and beyond.
The Group intends to leverage the deep industry knowledge of its board, its partners and the enlarged team both, to grow current operations, as well as, to undertake due diligence on the commercial attributes of further target entities' business.
For further information on the Group please visit www.cybaplc.com and narfindustries.com , with the Company's Prospectus to be found at www.cybaplc.com/investor-relations/corporate-documents or contact:
Robert Mitchell
| CYBA | Tel: +44 (0) 20 3468 2212 |
Peter Krens | Tennyson Securities | Tel: +44 (0)207 186 9030 |
Important notice
The content of this announcement has not been approved by an authorised person within the meaning of the Financial Services and Markets Act 2000 (FSMA). This announcement has been issued by and is the sole responsibility of the Company. The information in this announcement is subject to change. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the Securities Act), and may not be offered or sold, directly or indirectly, in or into the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States. This announcement is not for release, publication or distribution, directly or indirectly, in or into the United States, Australia, Canada, the Republic of South Africa, Japan or any jurisdiction where to do so might constitute a violation of local securities laws or regulations (a Prohibited Jurisdiction). This announcement and the information contained herein are not for release, publication or distribution, directly or indirectly, to persons in a Prohibited Jurisdiction unless permitted pursuant to an exemption under the relevant local law or regulation in any such jurisdiction.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.